ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $625,000 | +7.0% | 100,000 | 0.0% | 0.01% | +14.3% |
| Q3 2015 | $584,000 | -29.4% | 100,000 | 0.0% | 0.01% | -22.2% |
| Q2 2015 | $827,000 | +0.4% | 100,000 | 0.0% | 0.01% | -10.0% |
| Q1 2015 | $824,000 | +19.9% | 100,000 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $687,000 | +27.2% | 100,000 | 0.0% | 0.01% | +14.3% |
| Q3 2014 | $540,000 | -15.2% | 100,000 | 0.0% | 0.01% | -12.5% |
| Q2 2014 | $637,000 | -21.0% | 100,000 | 0.0% | 0.01% | -27.3% |
| Q1 2014 | $806,000 | -83.7% | 100,000 | -86.2% | 0.01% | -89.2% |
| Q4 2013 | $4,945,000 | – | 725,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $94,961,000 | 26.95% |
| Consonance Capital Management LP | 8,845,742 | $65,370,000 | 9.25% |
| Opaleye Management Inc. | 1,250,000 | $9,238,000 | 6.17% |
| Tamarack Advisers, LP | 2,100,000 | $15,519,000 | 5.95% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 293,352 | $2,168,000 | 1.62% |
| Camber Capital Management LP | 4,000,000 | $29,560,000 | 1.43% |
| Palo Alto Investors LP | 2,535,117 | $18,735,000 | 1.42% |
| Granite Point Capital Management, L.P. | 430,890 | $3,184,000 | 1.37% |
| 1492 Capital Management LLC | 202,500 | $1,496,000 | 1.34% |
| HighVista Strategies LLC | 869,100 | $6,423,000 | 1.23% |